EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Alendronate-induced morphological changes in osteoclasts and eroded pores during cortical bone remodeling in lactating Sprague Dawley rats

Birgitte Villadsen, Pankaj Shitole, Simone S R Nielsen, Joseph M Wallace, Malene Nielsen, Frank C Ko, Dale R Sumner, Kyle Anderson, Bryan Dulion, Ryan D Ross, Thomas L Andersen

Bone · 2026

DOI: 10.1016/j.bone.2026.118058 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bone, 2026. Verfasst von Birgitte Villadsen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Bone Histology (MBH) Lab, Department of Clinical Research, University of Southern Denmark, Odense, Denmark; Danish Spatial Imaging Consorti…. Hauptthemen laut MEDLINE: Alendronate, Bone Remodeling, Osteoclasts, Lactation. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bisphosphonates (BPs) are widely used to treat bone complications, yet their impact on the coupling between resorption and formation during cortical bone remodeling remains incompletely understood. We investigated associations between short-term alendronate treatment and osteoclast morphology, intracortical pore dynamics, and osteoprogenitor organization in a synchronized rat model of endo- and intracortical bone remodeling induced by lactation and dietary calcium restriction. Twenty-four lactating Sprague Dawley rats were randomized to vehicle, alendronate (28 μg/kg, twice weekly), or raloxifene (1 mg/kg, five times weekly) with raloxifene serving as a comparative control, for seven days under a low-calcium diet. Femurs were analyzed by micro-CT, histomorphometry, and multiplex RNA in situ hybridization combined with AI-driven image analysis. Alendronate was associated with a higher proportion of eroded pores (29% vs. 12% in controls) and lower density of formative pores (5.2 vs. 10.0 pores/mm2), indicating a prolonged reversal-resorption phase. Osteoclasts on endocortical surfaces were significantly larger (208 ± 37 μm2vs. 146 ± 46 μm2) and contained more nuclei (2.8 ± 0.40 nuclei vs. 2.2 ± 0.46 nuclei) under alendronate treatment, consistent with enhanced fusion. Osteoprogenitor abundance and spatial organization did not differ between treatment groups. Region-specific structural differences included increased midshaft porosity and larger distal metaphyseal cortical area in alendronate-treated rats. Raloxifene was associated with minimal differences on early remodeling events. Together, these findings support the interpretation that short-term bisphosphonate treatment is associated with early alterations in cortical remodeling dynamics under high-turnover conditions and highlight the importance of site-specific evaluation within defined physiological remodeling contexts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlendronateBone RemodelingOsteoclastsLactationCortical BoneAnimalsRats, Sprague-DawleyFemalePorosityRatsFemurX-Ray MicrotomographyRaloxifene Hydrochloride

Stichwörter der Autor:innen

BisphosphonatesBone histomorphometryBone remodelingCortical bone remodelingMicro-CTOsteoclast morphologyRat model

Substanzen

AlendronateRaloxifene Hydrochloride

Autor:innen und Institutionen

  • Molecular Bone Histology (MBH) Lab, Department of Clinical Research, University of Southern Denmark, Odense, Denmark; Danish Spatial Imaging Consortium (DanSIC), University of Southern Denmark, Odense, Denmark. Electron…
  • Dept. of Anatomy & Cell Biology, Rush University Medical Center, Chicago, USA.
  • Molecular Bone Histology (MBH) Lab, Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
  • Weldon School of Biomedical Engineering, Purdue University, Indianapolis, USA.
  • Danish Spatial Imaging Consortium (DanSIC), University of Southern Denmark, Odense, Denmark; Dept. of Pathology, Odense University Hospital, Odense, Denmark.
  • Dept. of Anatomy & Cell Biology, Rush University Medical Center, Chicago, USA; Department of Orthopedic Surgery, Rush University Medical Center, Chicago, USA.

Förderung

  • National Institutes of Health

Zitieren

APA

Villadsen, B., Shitole, P., Nielsen, S. S. R., Wallace, J. M., Nielsen, M., Ko, F. C., Sumner, D. R., Anderson, K., Dulion, B., Ross, R. D., & Andersen, T. L. (2026). Alendronate-induced morphological changes in osteoclasts and eroded pores during cortical bone remodeling in lactating Sprague Dawley rats. Bone. https://doi.org/10.1016/j.bone.2026.118058

Vancouver

Villadsen B, Shitole P, Nielsen SSR, Wallace JM, Nielsen M, Ko FC, et al. Alendronate-induced morphological changes in osteoclasts and eroded pores during cortical bone remodeling in lactating Sprague Dawley rats. Bone. 2026. doi:10.1016/j.bone.2026.118058

BibTeX
@article{Villadsen2026,
  author = {Villadsen, Birgitte and Shitole, Pankaj and Nielsen, Simone S R and Wallace, Joseph M and Nielsen, Malene and Ko, Frank C and Sumner, Dale R and Anderson, Kyle and Dulion, Bryan and Ross, Ryan D and Andersen, Thomas L},
  title = {Alendronate-induced morphological changes in osteoclasts and eroded pores during cortical bone remodeling in lactating Sprague Dawley rats},
  journal = {Bone},
  year = {2026},
  doi = {10.1016/j.bone.2026.118058}
}
Kostenlos starten →